[1]
M. Lopo Vitorino and I. Pavão Martins, “Efficacy and Safety of Fremanezumab in Patients with Migraine: Real-World Evidence in a Private Neurological Center”, Sinapse, vol. 22, no. 2, pp. 56–65, Apr. 2024.